 |
|
February 1, 2010 |
|
MESSAGE FROM THE DIRECTORI received a document from AACR that has been circulated to the AACR Public Affairs Legislative Committee. It relates to a new piece of legislation by Representative Capps that was introduced last year, and may have legs this year. Regardless of its passage, this legislation provides a roadmap for a public policy oriented perspective on the need for a more public screening/detection/survivorship effort by the NCI and HHS. (Click here to view document) I have provided only a summary that I received with two caveats:
My further perspectives are as follows: In the context of maturing our approach to individualized therapeutic clinical trials, we need to consider the evolution and complexity of both early screening and risk assessment, followed by premalignant management, interventions that are risk adjusted, and also management of advanced cancers using biomarker-driven therapeutics. Please note the emphasis in the following areas:
I wonder whether we should give consideration to the following:
How might we develop a strategy for cancer center investments? I look forward to a dialogue with individual cancer center members and program leaders on these topics. Stanton Gerson, MD KUDOSA paper co-authored by Harihara Baskaran and biomedical engineering doctoral student Saheli Sarkar, titled Insights Into the Roles of Non-Muscle Myosin IIA in Human Keratinocyte Migration, was recognized as a 2009 Outstanding Cellular and Molecular Bioengineering Paper at the Biomedical Engineering Society's Annual Meeting. Georgia Wiesner, MD and Timothy O'Brien, MD have been named CWRU Master Teachers for the 2009-2010 academic year. The School of Medicine initiated this program last year to recognize individuals who over a long period of time and with sustained effort have contributed to innovation and excellence in medical and/or graduate educate. FUNDING OPPORTUNITY– Samuel Waxman Cancer Research FoundationThe Case CCC has been invited to submit ONE application for a Samuel Waxman Cancer Research Foundation Institute Without Walls grant. Investigators of the Foundation have long been interested in differentiation therapy of cancer- the notion that the cancer cell can be re-programmed to re-acquire aspects of normal cell differentiation including terminal cell division and programmed cell death. In 2010, the Foundation will offer several grants of up to $100,000 per year to fund novel research along these lines. Applicants must be established investigators with a tenure-track or tenured appointment, holding as PI at least one grant from a major funding source, such as NIH, NSF, DOD or ACS. The applicant may hold a K08, K99/R00, or other major career transition grant, such as those from Burroughs Wellcome Foundation or HHMI. The goal of the program is to leverage existing cancer research expertise into translational and collaborative cancer research. Please send a one-page proposal and biosketch to Bonnie West (bonnie.west@case.edu by Monday, February 15. Completed applications are due to Waxman Foundation April 1. For more information, please click here. MARK YOUR CALENDARS– Oncomine WorkshopMark your calendars for an Workshop on Thursday, March 4 at 2:00 pm in WRB 1413. Come hear presenter, Oncomine's Gary Daubresse, explain how this powerful software and database can benefit your proposal writing and cancer research. Light refreshments will be served. This workshop is presented by the Case CCC/Gene Expression and Genotyping Facility (GEGF) and ONCOMINE. Contact Patrick Leahy patrick.leahy@case.edu, 368-0761 with any questions. MARK YOUR CALENDARS– State-of-the-Science Conference on Colorectal Cancer Screening and Post-Conference Press TelebriefingAn NIH State-of-the-Science Conference on Enhancing Use and Quality of Colorectal Cancer Screening will be held February 2-4, 2010. After weighing the results of a systematic literature review, expert presentations, and audience input, an impartial, independent panel will prepare a statement of its collective assessment of the available evidence with regard to six predetermined conference questions. The panel's press telebriefing will highlight its findings and implications for the public. For details, please click here. FUNDING OPPORTUNITY– CanLiv's 2010 Translational Research Grants ProgramCanLiv, the Hepatobiliary Cancers Foundation, is accepting applications for the 2010 Translational Research Grants Program for Cancers of the Bile Ducts and Gallbladder Young Investigators Award. This award provides funding to promising new investigators to encourage and promote translational research in cancers of the gallbladder and/or bile ducts (cholangiocarcinoma). CanLiv's definition of translational research is hypothesis-driven research that seeks to expand understanding of carcinogenic mechanisms in cancers of the liver, gallbladder and/or bile ducts and has significant likelihood to imminently lead to new therapeutic options for patients. Applicants must hold an MD, DO, PhD or DSci degree and be in their first to third year of a full time, primary faculty appointment in a clinical, basic, or translational science department at an academic medical institution. For foreign-trained physicians or scientists, equivalency will be determined on a case by case basis. Applicants must be tenure-track scientists at the level of Assistant Professor, but cannot be tenured or under review for tenured academic positions at the time of application submission. Deadline March 5 For details, please click here. |
EVENTS**All events are open to anyone interested in attending February 1Pathology Graduate Student Dissertation Defense Structural Biology Seminar SDIG Meeting Physiology & Biophysics Seminar February 2Taussig Cancer Institute Core Curriculum Series February 3Grand Rounds February 4Taussig Cancer Institute Core Curriculum Series Neurosciences Seminar February 5Hem/Onc Fellows Seminar Taussig Cancer Institute Grand Rounds Olof Pearson Lecture Cancer Center Research in Progress Seminar more UPCOMING CANCER CENTER SYMPOSIUMS & EVENTSCase CCC Scientific Retreat ADDITIONAL UPCOMING SEMINARS & EVENTS12th International Symposium on Anti-Angiogenic Agents: Angio 2010 Recent Advances and Future Directions in Basic and Clinical Cancer Research AACR-JCA 8th Joint Conference on Cancer Genomics, Epigenomics, and the Development of Novel Therapeutics 13th Annual Meeting of the Translational Research Cancer Centers Consortium AACR 101st Annual Meeting |
FUNDING OPPORTUNITY– DOD Ovarian Cancer Research ProgramThe DOD is accepting applications for Ovarian Cancer Research Program (OCRP) Pilot Awards. FY10 OCRP is supporting innovative ideas that will drive the field forward and reduce the burden of ovarian cancer in the future. In addition, the OCRP is promoting unique partnerships and fostering the next generation of investigators in ovarian cancer research. These awards support conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer forward. Research priorities should include a testable hypothesis based on strong scientific rationale. Successful projects should provide a catalyst to expand or modify current thinking and/or approaches in ovarian cancer research. Pre-Application Deadline: March 11 For more information, please click here. FUNDING OPPORTUNITY– DOD Prostate Cancer Research ProgramThe DOD is accepting applications for Prostate Cancer Research Program (PCRP) Idea Development and Synergistic Idea Development Awards. The goals of the FY10 program are aimed towards eliminating death and suffering from prostate cancer. All applications for these awards should address at least one of the following PCRP overarching challenges: develop effective treatments for advanced prostate cancer, and distinguish lethal from indolent disease. Pre-Application Deadline: March 3 For more information, please click here. MESSAGE FROM DR. ERNEST BORDEN– Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC)The CTC/CEC core has initiated several investigator-initiated pilot studies and has begun to see planning for those which will be externally funded. We continue to encourage you, however, to develop new ideas for exploring and validating this technology. In addition to quantitation of these rare circulating cells, we are also now ready to undertake isolation of macromolecules for analysis. The isolated preparations will be provided back to you for assessment of expression in your laboratory or that of a collaborator. These proposals should involve pilot studies for which technical feasibility and preliminary data needs to be established in order to lead to external funding and would normally be for evaluation of 10-20 samples. We will require the following information (limited to 1 page) for consideration for pilot studies:
If you have any questions please do not hesitate to discuss with John Pellecchia or myself. Please submit your 1 page proposals to John Pellecchia at pellecj@ccf.org. Final approval to proceed with your pilot study will be granted by Dr. Derek Raghavan and myself and should normally be available within a week of submission. NCI CANCER BULLETINFeatured Article Cancer Research Highlights Guest Director's Update: Dr. Paulette S. Gray, Director, NCI Division of Extramural Activities MARK YOUR CALENDARS– NCI 3rd Annual Biospecimen Research Network SymposiumRegistration is now open and abstracts are being accepted for NCI's 3rd Annual Biospecimen Research Network Symposium, Advancing Cancer Research Through Biospecimen Science, March 24-25 in Bethesda, Maryland. The symposium will address the significant impact of pre-analytical biospecimen variables on cancer research and molecular medicine. Hosted by NCI's Office of Biorepositories and Biospecimen Research, the meeting will bring together leaders in the fields of biospecimen research, genomics, proteomics, oncology, pathology, biobanking, hospital administration and pharmaceutics as well as patient advocates. For details, please click here. FUNDING RESOURCES- Links to Funding Resources and Updated NIH Forms Available on Case CCC WebsiteThe Case CCC Funding Resources page has links to the following important resources:
Be sure to bookmark the links for easy future reference. FUNDING OPPORTUNITY– ACS Cancer Research FellowshipA Call for Applications was recently released for the ACS Cancer Research Fellowship, which is intended to strengthen the field of cancer research by attracting outstanding clinicians and scientists into careers in oncology upon completion of their specialty training and to engage them in basic or clinical academic cancer research. The fellowship is not intended for those already on a research track. Deadline: March 3 For more information, please click here. |
CALL FOR APPLICATIONS– 2010 NASA Space Radiation Summer SchoolApplications are now being accepted for the 2010 NASA Space Radiation Summer School. Up to 15 students will be selected for the course to be held this summer at the Brookhaven National Laboratory (BNL) in Long Island, NY from May 20 – June 11. The goal of the course is to provide scientific and practical information to students and scientists who are either new to the NASA program or to charged particle radiobiology. At the completion of the summer school, students will have received the full complement of training required to conduct their own experiments at BNL. Both foreign nationals and US citizens may apply to the program. All selected students must satisfy BNL and Department of Energy safety and security requirements in order to be admitted. Due to the intense nature of the course, applicants must demonstrate oral and written proficiency in the English language. Deadline: February 28 For more information, please click here. FUNDING OPPORTUNITY— Title Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas (RC4)NIH is accepting applications for the "Title Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas" (RC4) (RFA-OD-10-005). This program will support projects that address research endeavors in specific areas that will benefit from significant three-year funds without the expectation of continued NIH funding beyond this period. The research supported by the program should have high short-term impact, and a high likelihood of enabling growth and investment in biomedical research and development, public health, and health care delivery. This FOA solicits applications proposing to develop and implement critical research innovations in one or more of the following five thematic areas:
Only applications for projects that require $500,000 or more in total costs per year are expected to be considered for funding. LOI Deadline: February 15 (requested, not required) For details, please click here. Case CCC Leadership would like to review potential responses, and can assist in developing themes as responsive to the RFA. shRNA CLONE AVAILABILITYThe Small Molecule Screening Core (SMSC) has negotiated an opportunity to order shRNA clones from Sigma (in the form of glycerol stocks) for LRI and CWRU researchers for a very low price on a per clone basis. To order, please contact Anna Kondratova (kondraa@ccf.org, 445-3503). The next order will be in March, but existing clones can be purchased at any time. Also, the SMSC has small aliquots of secondary antibodies available for purchase; each set is conjugated with DyLight 488 and DyLight 594 fluorescent dyes (Jackson ImmunoResearch Laboratories). The antibodies work well in place of fluorescein/Alexa488 & Texas Red conjugates. Please click here for more information. FACULTY CANDIDATE SEARCH– Associate Director for Basic ResearchThe Case CCC is currently accepting applications for the position of Associate Director for Basic Research. As we continue our search, we ask that people in the Cancer Center community encourage any qualified candidate to apply for the position. If you would like to nominate someone for the position, please contact Tracy Rehl (tracy.rehl@case.edu). Click here to view the job description. CASE CCC ON FACEBOOK AND LINKEDIN– Join Us!We are always trying to foster communication and collaboration across the cancer center community any way that we can. The Case CCC has set up a page on Facebook and LinkedIn, so please become a fan of us on Facebook or join our group on LinkedIn, and encourage others to do so as well. Please help us spread the word. We encourage you to post events, relevant news articles, items of discussion, etc… Your feedback is appreciated! CALL FOR APPLICATIONS– K12 Clinical Oncology Research Training ProgramThe Case CCC invites applications for its two-year NCI-funded K12 Clinical Oncology Research Training Program, led by Stanton Gerson, MD, Director, and Alvin Schmaier, MD, Co-Director. This career development program provides interdisciplinary training in clinical and translational oncology research for clinical oncologist who are interested in pursuing academic research careers as oncology physician scientists. Application Deadline: February 28 For more information and application materials, please click here. |
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES |
|
|
ACS Ohio Division Joseph S. Silber Student Summer Fellowship |
Hope Street Kids |
NIH Bulletin – Notices and Funding OpportunitiesNotice of Correction to PA-09-186 (NOT-OD-10-057) National Institutes of Health |
|
| Produced by: Gillian Irwin Todd 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
| If you have trouble viewing this page, click here to view the newsletter online on our website. | |